256P PI3K mutation is associated with reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer

Autor:	Keechilat Pavithran, W.M. Jose, D.K. Vijaykumar, S. Soman, H. Jayamohanan, P.S. Ariyannur
Rok vydání:	2021
Předmět:	Oncology business.industry Mutation (genetic algorithm) Cancer research Medicine Hematology Sensitivity (control systems) business medicine.disease Metastatic breast cancer PI3K/AKT/mTOR pathway
Zdroj:	Annals of Oncology. 32:S471
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.539
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f781e0a80c6ccab509e9045ec940b9ad https://doi.org/10.1016/j.annonc.2021.08.539 Zobrazit plný text záznamu